文献速递物质与行为成瘾精神分裂症与精神病性障碍心境障碍

多基因因素对气球模拟风险任务表现的影响

Polygenic contributions to performance on the Balloon Analogue Risk Task.
PubMed 文献 · Mol Psychiatry · 2023-08-15

研究在两项欧洲血统样本中检验气球模拟风险任务(BART)表现的多基因架构,发现一个数据集构建的多基因风险评分可预测另一数据集的任务表现(r=0.13,p=0.000012),MEGA-GWAS识别出IGSF21附近单核苷酸多态性rs12023073(p=3.24×10-8),自报大麻使用的多基因风险评分可预测BART行为。

要点

  • BART表现具有多基因架构,PRS可跨样本预测风险决策行为。
  • MEGA-GWAS识别出IGSF21附近rs12023073与BART表现相关,需复制验证。
  • 自报大麻使用的PRS可预测BART行为,提示风险决策与大麻使用存在遗传重叠。

核心结论

  • BART所测风险决策具有多基因架构,并与大麻使用存在遗传重叠。

研究设计与样本

  • 两项独立欧洲血统样本:样本一n=1138,含健康参与者及53例精神分裂症、42例双相障碍、47例ADHD患者;样本二n=911,排除近期治疗各类精神障碍但未排除ADHD。
  • 参与者提供DNA并完成BART,以平均调整泵数作为指标;在一个数据集构建PRS并在另一数据集复制,随后进行全基因组MEGA分析。

主要发现

  • 一个数据集的BART表现PRS可预测复制样本的任务表现(r=0.13,p=0.000012,pFDR=0.000052)。
  • 反向分析同样显示预测作用(r=0.09,p=0.0083,pFDR=0.04)。
  • 排除精神疾病诊断参与者后结果相似。
  • MEGA-GWAS识别出IGSF21附近单个SNP rs12023073(p=3.24×10-8),该蛋白参与抑制性脑突触。
  • 自报大麻使用的PRS可预测MEGA-GWAS样本的BART行为(p=0.00047,pFDR=0.0053),而自报风险偏好或精神疾病状态未显示预测作用。

关键数值与推荐

  • BART表现PRS跨样本预测:r=0.13,p=0.000012,pFDR=0.000052;反向r=0.09,p=0.0083,pFDR=0.04。
  • MEGA-GWAS显著SNP:rs12023073,p=3.24×10-8。
  • 大麻使用PRS预测BART行为:p=0.00047,pFDR=0.0053。

临床怎么用

  • BART表现的多基因评分可为风险决策相关精神障碍的遗传研究提供内表型指标。
  • 大麻使用与风险决策的遗传重叠提示临床评估物质使用时应关注风险决策特征。

局限性

  • MEGA-GWAS识别的rs12023073需复制样本验证。
  • 样本限于欧洲血统,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Risky decision-making is a common, heritable endophenotype seen across many psychiatric disorders. Its underlying genetic architecture is incompletely explored. We examined behavior in the Balloon Analogue Risk Task (BART), which tests risky decision-making, in two independent samples of European ancestry. One sample (n = 1138) comprised healthy participants and some psychiatric patients (53 schizophrenia, 42 bipolar disorder, 47 ADHD); the other (n = 911) excluded for recent treatment of various psychiatric disorders but not ADHD. Participants provided DNA and performed the BART, indexed by mean adjusted pumps. We constructed a polygenic risk score (PRS) for discovery in each dataset and tested it in the other as replication. Subsequently, a genome-wide MEGA-analysis, combining both samples, tested genetic correlation with risk-taking self-report in the UK Biobank sample and psychiatric phenotypes characterized by risk-taking (ADHD, Bipolar Disorder, Alcohol Use Disorder, prior cannabis use) in the Psychiatric Genomics Consortium. The PRS for BART performance in one dataset predicted task performance in the replication sample (r = 0.13, p = 0.000012, pFDR = 0.000052), as did the reciprocal analysis (r = 0.09, p = 0.0083, pFDR=0.04). Excluding participants with psychiatric diagnoses produced similar results. The MEGA-GWAS identified a single SNP (rs12023073; p = 3.24 × 10-8) near IGSF21, a protein involved in inhibitory brain synapses; replication samples are needed to validate this result. A PRS for self-reported cannabis use (p = 0.00047, pFDR = 0.0053), but not self-reported risk-taking or psychiatric disorder status, predicted behavior on the BART in our MEGA-GWAS sample. The findings reveal polygenic architecture of risky decision-making as measured by the BART and highlight its overlap with cannabis use.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Nurmi EL, Laughlin CP, de Wit H, et al. Polygenic contributions to performance on the Balloon Analogue Risk Task. Mol Psychiatry. 2023. PMID: 37582857. doi:10.1038/s41380-023-02123-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。